Mitochondrial metabolism is a tightly regulated process that plays a central role throughout the lifespan of hematopoietic cells. Herein, we analyze the consequences of the mitochondrial oxidative phosphorylation (OXPHOS)/metabolism disorder associated with the cellspecific hematopoietic ablation of apoptosis-inducing factor (AIF). AIF-null (AIF −/Y ) mice developed pancytopenia that was associated with hypocellular bone marrow (BM) and thymus atrophy. Although myeloid cells were relatively spared, the B-cell and erythroid lineages were altered with increased frequencies of precursor B cells, pro-erythroblasts I, and basophilic erythroblasts II. T-cell populations were dramatically reduced with a thymopoiesis blockade at a double negative (DN) immature state, with DN1 accumulation and delayed DN2/DN3 and DN3/DN4 transitions. In BM cells, the OXPHOS/metabolism dysfunction provoked by the loss of AIF was counterbalanced by the augmentation of the mitochondrial biogenesis and a shift towards anaerobic glycolysis. Nevertheless, in a caspase-independent process, the resulting excess of reactive oxygen species compromised the viability of the hematopoietic stem cells (HSC) and progenitors. This led to the progressive exhaustion of the HSC pool, a reduced capacity of the BM progenitors to differentiate into colonies in methylcellulose assays, and the absence of cell-autonomous HSC repopulating potential in vivo. In contrast to BM cells, AIF −/Y thymocytes compensated for the OXPHOS breakdown by enhancing fatty acid β-oxidation. By over-expressing CPT1, ACADL and PDK4, three key enzymes facilitating fatty acid β-oxidation (e.g., palmitic acid assimilation), the AIF −/Y thymocytes retrieved the ATP levels of the AIF +/Y cells. As a consequence, it was possible to significantly reestablish AIF −/Y thymopoiesis in vivo by feeding the animals with a high-fat diet complemented with an antioxidant. Overall, our data reveal that the mitochondrial signals regulated by AIF are critical to hematopoietic decision-making. Emerging as a link between mitochondrial metabolism and hematopoietic cell fate, AIFmediated OXPHOS regulation represents a target for the development of new immunomodulatory therapeutics.
Introduction
Mitochondria are functional organelles that play a vital role during hematopoiesis by providing energy and by generating reactive oxygen species (ROS) that regulate proliferation, differentiation, and self-renewal [1] [2] [3] [4] . For example, a fine regulation of mitochondrial ROS production is needed to maintain the equilibrium between quiescent and cycling bone marrow (BM) hematopoietic stem cells (HSC) [2, [5] [6] [7] . In contrast, high levels of mitochondrial ROS are detrimental to HSC and can lead to their elimination by programmed cell death [7] . The relevance of mitochondrial oxidative phosphorylation (OXPHOS) in determining HSC fate is also signified by the metabolic changes that occur during the transition from a quiescent to a cycling/activated state [8] . Concerning thymopoiesis, less is known about the OXPHOS implication in the differentiation of double negative (DN) progenitor cells. However, a fine-tuning between ROS and glycolytic activation appears important for DN1-to-DN4 transitions [9, 10] . Apoptosis-inducing factor (AIF), a Janus mitochondrial protein that is encoded by the Aifm1 (Aif, Pdcd8) gene on the X-chromosome, has been implicated in maintaining mitochondrial electron transport chain (ETC) function [11] [12] [13] [14] . After its translocation to the nucleus following an apoptotic insult, AIF also participates in the modulation of caspase-independent programmed cell death [15] [16] [17] [18] [19] [20] [21] . Under pathological conditions, the mitochondrial function of AIF is critical to inhibiting tumor metastasis by modulating PTEN phosphatase activity [22] . Moreover, human mutations in AIF result in acute pediatric mitochondriopathies [23] [24] [25] . Concerning the immune system, studies in the Harlequin (Hq) mouse strain (which has a~70% reduction in AIF expression) indicate that, in peripheral mature T cells, low AIF expression leads to enhanced susceptibility of T-cell blasts to activation-induced cell death and reduced sensitivity to neglect-induced cell death. In this model, the HSC, B cells and other hematopoietic lineages do not exhibit apparent abnormalities [26, 27] . Contrary to these results, a work in which Aif was ablated around the DN3 stage of thymocyte development reported that AIF loss had no impact on T-cell development. In the same study, the use of the CD19-cre strain indicated that AIF was not required for B-cell development and function [28] .
Herein, by generating an original mouse model in which Aif was ablated early during hematopoiesis, we have broadly investigated the role of AIF and the OXPHOS metabolism in the development of immune cells. Our mouse strain demonstrates that early AIF deficiency provokes pleiotropic consequences on normal hematopoiesis, the arrest of thymopoiesis, and a delayed development of B-cell and erythroid lineages. Importantly enough, our mouse model also illustrates metabolic adaptive responses associated to OXPHOS dysfunction: BM cells shift towards anaerobic glycolysis, whereas thymocytes favor fatty acid β-oxidation (FAO).
Results

AIF ablation in hematopoietic cells resulted in pancytopenia and aberrant thymocyte, B-cell, and erythroid development
To investigate the influence of AIF in hematopoiesis, we crossed a newly generated Aifm1-floxed mouse with a Vav1-cre strain that drives early Cre recombinase expression specifically in hematopoietic cells, including HSC [29] . Excision of Aifm1 exon 11 on the X-chromosome generated a stop codon, which resulted in a male progeny null for AIF (AIF −/Y mice) (Supplementary Figure 1) . , the thymus of KO animals was markedly smaller (Fig. 1a) . The AIF −/Y newborns developed normally until they were 21 days old, and after that they presented signs of severe anemia (Fig. 1a, 28 -day-old mice pictures), which was followed by mice death (Fig. 1b) . White cells, red cells, and platelet counts confirmed that AIF −/Y mice displayed progressive pancytopenia (Fig. 1c) . Between 21 and 28 days after birth, AIF −/Y animals exhibited severe hypocellularity of the BM and spleen. Moreover, the number of thymocytes in these animals, close to zero at birth, did not increase with age. Finally, the lymph node cellularity was very low in the KO mice, with no observed evolution and even a complete collapse in the 28-day-old animals ( Fig. 1d) .
To better analyze the hematopoietic lineages in AIF
and AIF −/Y mice, we performed cell-specific immunophenotyping. In the BM, although no significant differences were recorded in 7-day-old mice, erythroid, macrophagic/ monocytic, B-lymphoid, and T-lymphoid cells were severely decreased in 21-and 28-day-old AIF −/Y animals ( Fig. 1e ). In the thymus of the KO mice, T-cell development was blocked at the CD4 − CD8 − DN stage ( Fig. 1f and Supplementary Figure 2 ). Our analysis of other hematopoietic lineages revealed that, in contrast to what had been previously reported in the Hq mouse strain [26, 27] or in the CD19-Cre mouse model [28] , the B-cell and erythroid lineages were also affected by the early AIF deficiency. This was manifested by increased frequencies of precursor B cells in the BM and spleen ( Fig. 1g and Supplementary Table 1) , as well as increased frequencies of pro-erythroblasts I and basophilic erythroblasts II in the spleen (Fig. 1h) . By crossing Aifm1-floxed mice with a tamoxifen inducible Rosa26-CreERT2 mouse strain [30] , we confirmed that the loss of AIF in 3-month-old adult mice also provoked major hematopoietic alterations. These included a reduction in BM and thymus cellularity, which resulted in death of the mice between 25 and 65 days after the first tamoxifen injection, and a significant delay in T-cell development ( Supplementary  Figures 3a-c) . Overall, these findings indicate that AIF ablation resulted in pleiotropic consequences that affected hematopoiesis in neonatal and adult mice.
AIF loss provoked mitochondrial OXPHOS dysfunction and BM metabolic recalibration
As indicated above, AIF has been implicated in maintaining ETC stability and function [12] [13] [14] . Thus, we tested whether the severe phenotype observed in AIF −/Y mice was directly related to OXPHOS dysfunction in BM cells. ETC integrity was verified using an immunoblot approach, which indicated that the AIF −/Y BM cells experienced a reduction in the mitochondrial complex I NDUFA9, complex III UQCRC2, and complex IV COX4I2 subunits. By contrast, complex II SDHA and complex V ATP5B proteins were not affected by the AIF loss ( Fig. 2a and Supplementary Figure 4a ). These observations are in accordance with the "solid-state" model of ETC structure that organizes the mitochondrial complexes I, III, and IV in a unique "supercomplex" entity in which the alteration in one complex directly affects the two others [31] [32] [33] . Note that the structural mitochondrial protein VDAC1 appears overexpressed in the BM KO cells, suggesting an augmentation of the mitochondrial mass. Morphologically, compared with WT cells, mitochondria from AIF −/Y cells lacked a normal tubular structure and exhibited swollen irregular tubules associated with changes in the internal membrane organization (Fig. 2b) . The monitoring of oxygen consumption rate (OCR) revealed that AIF −/Y cells exhibited a significant reduction in both basal oxygen consumption and total oxidative capacity ( Fig. 2c and Supplementary Figure 4b ). In spite of that, the complex I inhibitor amytal abolished the remaining oxygen consumption of AIF −/Y cells, indicating that complex I remains somewhat functional in these cells. Moreover, as indicated by the addition of the complex V inhibitor oligomycin, electron transport was still coupled to ATP synthesis ( Fig. 2c and Supplementary Figure 4b) . Finally, the detailed analysis of the individual complex activities, measured by monitoring OCR in permeabilized cells, revealed that ETC activities of AIF −/Y cells were~40 % lower than those measured in WT cells (Supplementary Figure 4c) . Together, the OXPHOS alterations associated to AIF deficiency in BM cells provoked a diminution in the mitochondrial transmembrane potential (ΔΨm) and an enhancement of mitochondrial ROS ( Fig. 2d and e and Supplementary Figures 3d and e) . At the cellular level, the results obtained confirm that the mitochondrial defects associated with AIF loss were counterbalanced in BM cells by the augmentation of mitochondrial mass (Fig. 2f) . This was accompanied by a shift to anaerobic glycolysis, as revealed by the increase in: (i) glucose uptake (Fig. 2g) ; (ii) extracellular acidification rate (ECAR) (Fig. 2h); and (iii) lactate release (Fig. 2i) . The inhibition of caspases does not modify this glycolytic picture (Supplementary Figure 5) , indicating that the metabolic change is not owing to the initiation of an apoptotic process. Anyhow, the metabolic reprogramming was further validated by a broad metabolomic approach, which corroborated that the components of the glycolytic pathway and the general carbohydrate metabolism were enhanced in AIF −/Y BM cells. The metabolomic approach also revealed that AIF-null BM cells had reinforced amino-acid metabolic pathways ( Fig. 2j and Supplementary (Fig. 3c) . Moreover, the colonies formed by all KO cells, which were significantly smaller than those generated by WT cells, were mainly derived from cells with an erythroid, granulocyte, or monocytic phenotype. At last, we demonstrated that the retroviral reintroduction of mAIF in KO cells significantly restored the clonogenic potential of AIF −/Y cells (Fig. 3d) .
Overall, our colony-forming approaches confirm that the proliferation and differentiation defects of these KO cells result from the AIF absence. We then performed both non-competitive and competitive transplantation assays to test the hematopoietic progenitor-repopulating capacities in vivo using CD45.2 donor cells that we injected into lethally irradiated CD45.1 recipient mice. In non-competitive assays,~50% of recipient mice grafted with AIF −/Y BM cells died. The surviving mice had very few CD45.2 donor cells in the blood or BM, as revealed by quantification at 2, 6, and 8 weeks post transplantation (Fig. 3e) . Similarly, in competitive transplantation experiments, AIF-deficient LSK cells yielded lower levels of reconstitution compared with WT LSK cells (Fig. 3f ). Finally, we tested in vivo the repopulating capacities of the AIF 
High levels of ROS induced AIF −/Y HSC and progenitors exhaustion
We next investigated the mechanisms that underlie AIFmediated HSC and progenitors exhaustion. We first observed that anaerobic glycolysis is enhanced in these AIF KO subsets (Fig. 4a) . Moreover, compared with WT cells, mitochondrial ROS levels were augmented (Fig. 4b) . Finally, AIF −/Y HSC and progenitors presented increased frequencies of DNA damage and cell death ( Fig. 4c-d ).
Using the antioxidant N-acetyl-cysteine (NAC), we verified whether the levels of ROS generated by the AIF lossassociated OXPHOS dysfunction (Fig. 2 ) compromised the viability of HSC and progenitors. We first confirmed that treatment of AIF −/Y BM cells with NAC suppressed the excess of mitochondrial ROS (Fig. 4e) . Further, using a colonyforming assay, we observed that the addition of NAC favored the development of AIF −/Y BM cells into colonies (Fig. 4f) .
Notably, in the presence of NAC, AIF −/Y BM cells also developed into a large number of immature GEMM colonies, which would have never formed in the absence of antioxidant. Finally, the addition of NAC in the drinking water administered to the dams allowed for the in vivo rescue of LT-HSC, ST-HSC, and MPP in the AIF −/Y newborns ( Fig. 4g ).
Mitochondrial OXPHOS regulated thymocyte differentiation and fate
To analyze the developmental defaults of the AIF −/Y thymocytes, we first performed detailed immunophenotyping. In E15.5 thymic lobes, only DN precursor thymocytes were observed and an analysis of DN1-to-DN4 subpopulations did not reveal significant differences between the WT and KO animals ( Fig. 5a and Supplementary Table 3a) . At E17.5, loss of AIF restricted both the DN3-to-DN4 transition and the generation of DP cells. Furthermore, thymus analysis in 7, 21, and 28-day-old mice indicated that Figure 7) . By using cKit/ CD24 co-labeling, we further analyzed the phenotype of the DN1 AIF −/Y prothymocytes. Compared to WT, the DN1 compartment of the AIF-null 7-day-old mice showed a relative high number of DN1b cells, low levels of DN1c prothymocytes, and the accumulation of the less proliferative DN1e subset. In 21-day-old mice, as expected by the diminution of the CLP precursors in the BM (Fig. 3b) Figures 3h and i) . Surprisingly, contrary to BM cells, these mitochondrial alterations were not counterbalanced either by an increase in the mitochondrial mass or by a shift towards anaerobic glycolysis ( Fig. 6e and f) . Consequently, the cellular ATP levels of the AIF −/Y thymocytes dropped significantly ( Fig. 6g and Supplementary  Figure 3j ). Searching for a metabolic adaptive alternative in AIF −/Y thymocytes, we performed a quantitative-PCR approach that revealed the upregulation of three key FAO-facilitating enzymes: CPT1, ACADL, and PDK4 (Fig. 7a) . This overexpression was corroborated by RNAscope, a specific fluorescence in situ hybridization technique [34] (Fig. 7b) .
Note that the metabolic reprogramming induced by AIF loss in thymocytes, including the mitochondrial alterations, the low glycolytic rate, and the overexpression of FAOfacilitating enzymes, was confirmed in comparing the AIF Figure 9 ).
The ablation of AIF differentiated the metabolic flexibility of thymocytes and BM cells
Finally, following our above results and considering that a ketogenic diet has been shown to improve medical condition in children bearing ETC mutations [35] , we tested the possibility of reactivating thymopoiesis in vivo by eliminating the excess of ROS and feeding the dams with a high-fat diet (HFD) in which the major source of energy changed from carbohydrates to fatty acids [36] . We first demonstrated that NAC treatment efficiently suppressed the excess of mitochondrial ROS in AIF −/Y thymocytes (Fig. 7d) . Moreover, the treatment of the dams with HFD and, more evidently, with NAC + HFD restored the normal generation of ATP in the AIF −/Y thymocytes ( Fig. 7e and Supplementary Table 4a ). Strikingly, compared with that observed in animals fed in a standard carbon diet, thymocyte development was significantly reestablished in the AIF −/Y newborns fed with a HFD: (i) HFD alone favored the generation of DP thymocytes (a mean of~16 %) and (ii) a HFD + NAC combination allowed for a highly significant DP development (a mean of~40 %) ( Fig. 7f and Supplementary Table 4b ). These results confirm in vivo the 
Discussion
The mitochondrion acts as a metabolic hub that provides signals to direct the differentiation and fate of the immune cell subsets [1, 4, [37] [38] [39] [40] . In our study, we show that AIF has a critical role in determining the fate of hematopoietic cells. The loss of AIF triggers a mitochondrial endpoint, which results in pleiotropic effects on hematopoietic development, including BM aplasia, alterations in the development of the T-cell, B-cell, and erythroid lineages, and a DN1 thymopoiesis blockade. Our findings also reveal that, in cases of OXPHOS dysfunction, BM cells and thymocytes reprogram (Fig. 8) .
In addition to its role in cell death [15-18, 20, 41] , AIF is indispensable for OXPHOS function and mitochondrial energy production [11] [12] [13] [42] [43] [44] . According to the model of supercomplex organization [31, 33] , alterations on the ETC architectural structure yield OXPHOS dysregulation, along with respiratory defects, a reduced capacity for ATP production, and altered ROS generation; the same defects could be observed in AIF −/Y BM cells and thymocytes. Of note, AIF deficiency does not yield fully defective mitochondria. Indeed, this mitochondrial functionality appears critical for maintaining hematopoietic cell viability in neonatal mice and for yielding adaptive mitochondrial metabolic responses. The role of AIF in the immune system was initially assessed in the Hq strain, which is not an AIF knockout mice [26, 27] . In addition, the mitochondrial role of AIF in the T-and B-cell lineages was analyzed more recently by using Lck-Cre and CD19-Cre mouse models [28, 45] . A comparison between the immune alterations reported in these works and those characterizing the AIF −/Y model presented here indicates that the generation of bona fide hematopoietic AIF KO mice reveals a greater role for AIF in hematopoiesis. Specifically, thymocytes from Hq mice exhibited higher ROS levels, which appeared to be responsible for delayed DN3 development. By contrast, the T-cell developmental defects in our AIF −/Y mice were rather strong: DP cell generation was not delayed but, instead, was fully compromised. This could be observed in fetuses, thus very early during thymic development. The analysis of the earliest thymic T-lineage precursors [46] reveals that their progressive loss is a consequence of a BM perturbation. However, it seems that the DN1a/DN1b subsets of the AIF −/Y mice are still able to generate the DN2 population [46] that is always present in the thymus of the animals. Therefore, we could hypothesize that the delayed DN2/DN3 and DN3/DN4 transitions are independent from the canonical T precursors loss and, consequently, are associated to the OXPHOS/metabolic defaults caused by the AIF deficiency. Overall, our results seem to indicate that the developmental defaults characterizing the AIF −/Y thymocytes are cell intrinsic. The feeding of AIF −/Y dams with an HFD allows for the generation of DP thymocytes without Figure 10 ). Thus, it seems that the change of energy source is enough for the existing thymocytes to progress towards a DP phenotype.
In contrast to our results (and the results reported in the Hq strain) [26, 27] , the immune alterations measured in the Lck-Cre model indicate that Aif ablation is associated with a loss in the number of peripheral T cells without defects in thymocyte development [28, 45] . This disagreement can be explained by the earlier elimination of AIF in our mice model compared to the latest Aif ablation in the Lck-Cre (around the DN3 stage). Indeed, the blockade at the DN stage observed in our AIF −/Y mice, with alterations in the DN1, DN2, and DN3 stages, cannot be detected in the Lck-Cre animals. Of note, the adjustment in the mitochondrial metabolism profoundly alters DN1-to-DN4 thymocyte development [9, 10] . Remarkably, in contrast to previous results on Hq and CD19-Cre AIF KO mouse models [26] [27] [28] , our findings originally indicated that the loss of AIF undoubtedly affected B-cell and erythrocyte development. Here, the significant loss of T-cells observed in our mice model could also be implicated in the delayed B-cell development, as reported in other mice models [47] . AIF deficiency leads to impaired survival of HSC, resulting in exhaustion of their pool, a reduced capacity to differentiate into colonies in methylcellulose assays, as well as an absence of cell-autonomous HSC repopulating potential in vivo. All these features appear to be a consequence of the high levels of ROS associated to the loss of AIF. ROS are toxic products of oxidative metabolism, which are necessary for intracellular signal transduction but can impair cellular functions when present in excess [48, 49] . An efficient way for HSC and progenitor cells to limit the excess of ROS is to favor anaerobic glycolysis over OXPHOS [1, 6] . Accordingly, we observed an increased use of glycolysis in AIF −/Y BM cells. In the presence of NAC, this metabolic shift seemed to be crucial for the rescue observed in both in vitro and in vivo experiments. Indeed, BM cells seemed to be exclusively adapted to a carbon metabolism and, contrary to thymocytes, appeared unable to shift towards FAO (Supplementary Figure 10a ). The rescue of the HSC described in Fig. 4g failed when changing the energy source from carbohydrates to fatty acids, a reaction observed even in the NAC presence (Supplementary Figure 10b) . These results are in line with previous publications that, in similar feeding conditions, demonstrate that HFD causes decreased proliferation in LSK cells and a general suppression of progenitor cell populations in the BM [50] . ROS scavenging is also beneficial for T-cell rescue in AIF −/Y mice, corroborating the previously reported detrimental role of uncontrolled mitochondrial ROS in thymocytes [51, 52] . However, the increased levels of ROS appear to be only partially responsible for the failure of AIF −/Y thymocyte development. The developmental blockade characterizing these thymocytes also seems related to the lack of energy generated by these cells in a carbon environment. Surprisingly, the AIF −/Y thymocytes could reprogram their metabolism by enhancing their capacity to assimilate fatty acids. As a result, the change of energy source from carbohydrates to fatty acids, combined with protection against the excess of ROS, significantly restores thymocyte development in AIF −/Y animals.
These results confirm that, as reported in other models with ETC alterations, it is possible to generate ATP by FAO in OXPHOS "damaged" mitochondria [53] . In future studies, it would appear necessary to analyze whether other pathways implicated in thymocyte metabolism reprogramming also have a role in our mouse strain (e.g., Akt activation has been linked to a blockade in the DN3-to-DN4 cell transition [54] and deletion of LKB1 results in accumulation of DN3 thymocytes and reduction in the number of thymocytes [55] [56] [57] ). Altogether, we have identified AIF as a new player that acts by fine-tuning the mitochondrial OXPHOS/metabolism in order to dictate the differentiation and fate of hematopoietic cells. We also revealed, in BM cells and thymocytes, the specific metabolic reprogramming associated to the dysfunction of the mitochondrial OXPHOS. It would be of interest to know whether similar phenomena occur in the immune cell compartments of patients suffering from mitochondriopathies. In any case, from a medical perspective, our data reveal potential therapeutic targets to regulate the immune responses in the context of autoimmunity, inflammation, or anti-tumor responses (e.g., by disrupting the mitochondrial metabolism).
Materials and methods
Mice
All mice were housed at the Cordeliers Center animal facility under strictly controlled, specific pathogen-free conditions (agreement B75-06-12). Experiments were performed in accordance with ARRIVE ethical guidelines and with the approval of the French Ministry of Agriculture (agreement 1675). Mice were maintained with a rodent diet (R03, Scientific Animal Food & Engineering Diets) and water was made available ad libitum in a vivarium with a 12-h light-dark cycle at 22°C. In specific experiments, dams were fed on a standard control diet (CD; D12450J; Research Diets) or a high-fat diet (HFD; D12492i; Research Diets) before mating and kept on the same diet during pregnancy and lactation.
To generate the hematopoietic cell-specific AIF −/Y mice, the exon 11 of Aifm1 (Pdcd8, Aif) was flanked by LoxP sites using standard gene-targeting techniques (Supplementary Figure 1) . After at least 15 episodes of interbreeding in the C57BL/6 J background, the ; Rosa26-CreERT2 − tamoxifen-injected mice were used as control (WT) animals. No significant differences were observed with the other non-AIF deleted genotypes generated by the crossing.
To perform the antioxidant treatment of the lactating mice, N-acetyl-L-cysteine NAC (Sigma) was administered to the dams in drinking water at 2 g/kg of body weight per day (starting 3 days after giving birth and until newborn sacrifice). Mice peripheral blood samples were collected in EDTA-coated tubes and cell counts were analyzed in an automated counter (Scil Vet abc; SCIL GmbH).
Flow cytometry
For the different immunophenotyping approaches, the cellular suspensions from thymi, spleens, and BM were labeled with the corresponding antibody in FACS Buffer (2 mM EDTA 2% FCS PBS), recorded in a FACSCanto II (BD Biosciences), and analyzed using the FlowJo software (TreeStar Inc). All flow cytometry samples were treated with FcBlock (2.4G2; BD Biosciences) prior to their incubation with primary antibodies, except when identifying the BM HSC subsets.
The following antibodies (clone) were used: CD44 (IM7), CD45R/B220 (RA3-6B2), CD34 (RAM34), CD127 (A7R34), CD3ε-PE (145-2C11), Gr-1 (RB6-8C5), CD69 (H1-2F3), Foxp3 (FJK-16s), CD135 (Flt3) (A2F10), CD45.1 (A20), CD150 (SLAM) (TC15-12F12. For detection of LT-HSC, ST-HSC, MPP, MEP, CMP, and GMP cells, BM cells were incubated with a cocktail of biotinylated antibodies against Mac-1α (CD11b), Gr-1 (Ly-6G/C), Ter119, CD3, CD4, CD8a, and B220 (BD Biosciences) followed by detection with streptavidin conjugated to PerCP-Cy5.5. Then, cKit, Sca-1, CD34, CD135, and CD16/32 fluorochrome-conjugated antibodies were added to the mix. To define CLP cells and following a similar approach, cKit, Sca1, and CD127 fluorochrome-conjugated antibodies were added to the initial cocktail. For congenic strain discrimination, anti-CD45.1 and anti-CD45.2 antibodies (BD Biosciences) were used.
For the analysis of the DN compartment, thymocytes were incubated with a cocktail of biotinylated antibodies against CD8a, Mac-1α (CD11b), Gr-1 (Ly-6G/C), Ter119, CD3, and B220 (BD Biosciences) followed by detection with streptavidin conjugated to PerCP-Cy5.5. Then, CD24, CD25, CD44, and cKit antibodies were added to the mix. DN1 subpopulations were defined as: DN1a (cKit+CD24 low), DN1b (cKit+CD24+), DN1c (cKit-CD24+), DN1d (cKit-CD24 low), and DN1e (cKit-CD24-).
Isolation of DN fraction was performed by negative selection. In brief, thymocytes were pre-incubated with a mix of CD4 and CD8 magnetically labeled antibodies (BD Biosciences) and then placed on the BD IMag Cell Separation System, following the manufacturer's instructions.
Mitochondrial and cellular analysis
For mitochondrial ROS, mitochondrial mass, and Δψm measurements, cells were incubated with MitoSOX (5 µM), Mitotracker Green and Mitotracker Red (100 nM each) (Invitrogen), respectively, before assessment in a FACSCanto II.
For analysis of glucose uptake, BM cells and thymocytes were incubated (30 min; 37°C) in glucose-free DMEM with 2-NBDG (100 μM; Invitrogen) prior to flow cytometry assessment.
For DNA damage detection, cells were first labeled for HSC markers, incubated with a cytofix-cytoperm buffer (20 min on ice), and washed twice in Permwash buffer (BD Biosciences). Cells were then incubated with anti-γH2AX antibody A; Millipore) and analyzed in a FACSCanto II.
Apoptosis (cell death) was assessed by flow cytometry using Annexin-V-APC (0.1 µg/ml; BD Biosciences) and 7AAD double labeling (1 µg/ml; BD Biosciences). In some experiments, BM cells and thymocytes were pretreated during 30 min with the broad-spectrum caspase inhibitor QVD-OPh (QVD, 1 µM) before performing metabolic and cytometric tests. ATP was analyzed in 10 4 BM cells or thymocytes with an ATP bioluminescent kit (Abcam) in an Infinite M100 PRO plate reader (Tecan) and expressed as total ATP or ATP/ADP ratio.
For lactate measurement, cells were cultured for 2 h in a serum-free medium and centrifuged. Then, the supernatant was used to quantify extracellular L-lactate with a kit from Cayman Chemical Company in an Infinite M100 PRO plate reader (Tecan).
Metabolomic approach
The whole metabolomic assay was performed on 3 × 10 7 BM cells by GC-TOF-MS on a LECO Pegasus III with an Agilent 6890 N GC system (Massy, France) and an Agilent 7683 automatic liquid sampler as described [58] . The column used was an RTX-5 w/integra-Guard (30 m, 0.25 mm internal diameter +10 m integrated guard column) (Restek, Evry, France). Metabolites were extracted from samples using a methanol/water mixture (80/20 v/v). Peak identity was established by comparison of the fragmentation pattern with MS available databases, using a match cut-off criterion of 700/1000 and by retention time using the alkane series as retention standards. The integration of peaks was performed using the LECO Pegasus software (Garges-lès-Gonesse, France). The relative amount of each metabolite was calculated on the basis of the corresponding peak area compared with an internal standard (Ribitol).
Clark electrode
OCR were measured in 5 × 10 7 BM cells as previously described [59] . Respiration was measured in nonpermeabilized cells under basal conditions and in response to the sequential addition of oligomycin (10 µM), fluorocarbonyl cyanide phenylhydrazone (FCCP; 5 µM), amytal (2 mM), and azide (5 mM). For the glutamine dependent assessment, BM cells were plated in unbuffered XF assay media (Agilent Technologies). Then, in ECAR measurements, Glucose (10 mM), Glutamine (2 mM), or Glucose+Glutamine (10 mM and 2 mM, respectively) were injected followed by 2-DG (500 mM) inhibition. In the OCR assessment, Glutamine (2 mM) and BPTES (3 µM) were sequentially injected.
Measurement of OCR, ECAR, FAO, and glutamine dependency by Seahorse
High-resolution fluorescent in situ hybridization by RNAscope (FISH by RNAscope)
RNAscope assessment was strictly performed following manufacturing procedures (Advanced Cell Diagnostics, inc.; ACD) [34] . In brief, thymocytes purified from AIF +/Y and AIF −/Y animals were fixed with 4 % paraformaldehyde for 30 min at 4°C, washed with PBS pH 7.2, centrifuged (Cytospin 3, Shandon) at 700 rpm for 3 min on Superfrost Plus slides, dehydrated and permeabilized by Protease III digestion (ACD) for 10 min at RT. Then, slides were hybridized with mouse Cpt1 (conjugated to Atto 550) and Peptidylprolyl Isomerase B (Ppib, conjugated to Alexa 488; mRNA control) probes. Nuclei were visualized using DAPI staining. Hybridization of a probe against the Bacillus subtilis dihydrodipicolinate reductase (DapB) gene was used as a negative control. The resulting hybridized slides were imaged using a LSM 710 Zeiss confocal microscope and analyzed using the image J software. RNAscope experiments were repeated three times on different slide sets with similar results.
Retroviral transduction in BM and FL cells
Murine AIF cDNA was cloned into the MSCV-IRES-GFP retroviral vector. Viruses were generated into 293 T cells After an overnight culture in RPMI 1640 supplemented with 10% FBS, 10 ng/ml mIL-3, 10 ng/ml mIL-6, and 10 ng/ ml mSCF, cells were spin-infected with either MSCV-IRES-GFP or MSCV-mAIF-IRES-GFP viral supernatants. Then, cells were plated in M3434 methylcellulose medium or transferred in recipient mice CD45.1 as described below. Note that the percentage of cell transduction is similar in FL and BM cells (~5 %). 
Transplantation assays
CFU assays
Whole FL cells or BM cells were plated in duplicate in MethoCult M3434 (StemCell Technologies) and cultured at 37°C in 5% CO2 for 10 days before colony counting. Colonies were scored according to morphological criteria [60] . In selected experiments, NAC (250 µM) was added to methylcellulose at the time of cell plating.
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